Diacomit

Active Ingredient(s): Stiripentol
FDA Approved: * August 20, 2018
Pharm Company: * BIOCODEX SA
Category: Anticonvulsant

Stiripentol, sold under the brand name Diacomit, is an anticonvulsant medication used for the treatment of Dravet syndrome - a serious genetic brain disorder.[5][6] The most common side effects include loss of appetite, weight loss, insomnia (difficulty sleeping), drowsiness, ataxia (inability to coordinate muscle movements), hypotonia (low muscle strength) and dystonia (muscle disorders).[5] Contents 1 Medical uses 2 Contraindications 3 Adver... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Diacomit 250 mg Oral Capsule
NDC: 68418-7939
Labeler:
Biocodex Inc.
Diacomit 500 mg Oral Capsule
NDC: 68418-7940
Labeler:
Biocodex Inc.
Diacomit 1 mg/mg Oral Powder, for Suspension
NDC: 68418-7941
Labeler:
Biocodex Inc.
Diacomit 1 mg/mg Oral Powder, for Suspension
NDC: 68418-7942
Labeler:
Biocodex Inc.